MC2 THERAPEUTICS
MC2 Therapeutics drives innovation and program development from a lean core organization in close collaboration with a network of highly specialized, fully integrated and contributing experts and service providers. In addition to our core team, MC2 Therapeutics employs a large number of retained external contributors and consultants enabling us to bring further expertise to our work.
MC2 THERAPEUTICS
Social Links:
Industry:
Pharmaceutical Therapeutics
Founded:
2006-01-01
Address:
Hørsholm, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.mc2therapeutics.com
Total Employee:
11+
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Apache Global Site Tag Sitelinks Search Box Euro
Similar Organizations
Corino Therapeutics
Corino Therapeutics is a private, development-stage biopharmaceutical company
Emplicure
Emplicure is a privately held Swedish research and product development focused pharmaceutical company.
Laboratorios Atral
Laboratorios Atral is a privately owned group of pharmaceutical company
Therawis
Therawis Pharma GmbH is a privately held, profitable oncology-specialized company.
Current Employees Featured
Founder
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-09 | Professor Lars Iversen joins MC2 Therapeutics as new Chief Medical Officer |
Official Site Inspections
http://www.mc2therapeutics.com Semrush global rank: 5.78 M Semrush visits lastest month: 1.44 K
- Host name: dedi5059.your-server.de
- IP address: 136.243.123.133
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "MC2 Therapeutics"
Management - MC2 Therapeutics
MC2 Therapeutics drives innovation and program development from a lean core organization in close collaboration with a network of highly specialized, fully integrated and contributing …See details»
Join MC2 Therapeutics
MC2 Therapeutics is continuously looking for engaged and highly skilled people that are driven by passion and a can-do attitude and who want to make a difference within their field of expertise. …See details»
About us - MC2 Therapeutics
MC2 Therapeutics is a private pharmaceutical company dedicated to improving the lives of people with plaque psoriasis and inflamed dry and itchy skin through innovative and effective …See details»
MC2 Therapeutics - Crunchbase Company Profile
MC2 Therapeutics drives innovation and program development from a lean core organization in close collaboration with a network of highly specialized, fully …See details»
News - MC2 Therapeutics
May 27, 2025 MC2 Therapeutics announces FDA acceptance of its new drug application for Wynzora™ Cream a perscription treatment of psoriasis. Read More.See details»
Mc2 Therapeutics AS (Mc2 Therapeutics AS) - synapse.zhihuiya.com
May 7, 2025 For additional information on MC2 Therapeutics, please visit https://www.mc2therapeutics.com Contact: Lonni Goltermann, +45 2018 1111, …See details»
MC2 Therapeutics - LinkedIn
MC2 Therapeutics | 1,339 followers on LinkedIn. Let’s redefine therapies together | MC2 Therapeutics is a private pharmaceutical company dedicated to improving the lives of people …See details»
Owners - MC2 Therapeutics
MC2 Therapeutics is a privately held company that is supported by strong owners. Read More.See details»
MC2 Therapeutics - Growth Outlook - Crunchbase
Companies with Similar Growth Organization Name Growth Score Industries Headquarters Location Description Kymera Therapeutics 92 Biotechnology, Health Care, Medical, …See details»
MC2 Therapeutics - LinkedIn
MC2 Therapeutics is a private pharmaceutical company dedicated to improving the lives of people with plaque psoriasis and inflamed dry and itchy skin through innovative and effective …See details»
MC2 Therapeutics - VentureRadar
"MC2 Therapeutics is a privately held pharmaceutical company focused on topical therapies for chronic inflammatory conditions. Using its proprietary PAD™ Technology MC2 Therapeutics is …See details»
Products - MC2 Therapeutics
MC2 Therapeutics is advancing in multiple areas with PAD™️ Cream Technology. The pipeline includes multiple PAD™ Cream psoriasis medications. Learn MoreSee details»
MC2 Therapeutics - Overview, News & Similar companies
Feb 26, 2024 View MC2 Therapeutics (www.mc2therapeutics.com) location in North Denmark, Denmark , revenue, industry and description. Find related and similar companies as well as …See details»
MC2 Therapeutics Announces Positive Phase 2a Results of Novel …
Oct 11, 2023 MC2-32 (RGRN-305) a first in class, oral therapy targeting multiple pathways involved in Hidradenitis Suppurativa (HS) achieves highly positive data in randomized, double …See details»
MC2 THERAPEUTICS LIMITED - Companies House
MC2 THERAPEUTICS LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
MC2 Therapeutics - LinkedIn
MC2 Therapeutics | 1.352 følgere på LinkedIn. Let’s redefine therapies together | MC2 Therapeutics is a private pharmaceutical company dedicated to improving the lives of people …See details»
MC2 Therapeutics - LifeScienceHistory.com
MC2 Therapeutics is a private pharmaceutical company dedicated to improving the lives of people with plaque psoriasis and inflamed dry and itchy skin through innovative and effective …See details»
MC2 Therapeutics Company Profile - Office Locations ... - Craft
MC2 Therapeutics has 5 employees across 3 locations. See insights on MC2 Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
MC2 Therapeutics Announces Completion of Enrollment in MC2 …
Dec 7, 2023 MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial MC2-25 CKD is a first-in-class drug candidate and a …See details»
MC2 Therapeutics Receives Positive Feedback from FDA
May 13, 2024 MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expansion Strategy On track to file IND in mid-2025 for a...See details»